Skip to main content

HEALTH

  • Pure Encapsulations launches new probiotic product

    SUDBURY, Mass. — Pure Encapsulations on Thursday introduced PureHeart Probiotic, the newest addition to the PureHeart Protocol: Screening + Supplements = Success line of nutritional supplements. 

    “With the proprietary probiotic strain Lactobacillus reuteri NCIMB 30242, PureHeart Probiotic offers evidence-based support from a new angle in clinical cardiology,” stated Kelly Heim, nutritional pharmacologist at Pure Encapsulations. “This exclusive formulation addresses basic aspects of lipid metabolism and vascular function.” 

  • GelStat finalizes deal for CBD Life Sciences, prepares to support GelStat Migraine relaunch and diet aid intro

    PALM CITY, Fla. — GelStat Corp. on Wednesday announced that it has closed the acquisition of CBD Life Sciences.

    Concurrent with the closing of the transaction, Larry Gershman has been appointed as CEO and chairman. Gerald Kieft, the company's prior CEO, will assume the position of CFO and be appointed to the board. 

  • Nelsons introduces vasoconstrictor-free hemorrhoid cream

    NORTH ANDOVER, Mass. — Nelsons on Thursday introduced Homeopathic H+Care Hemorrhoid Cream, a new hemorrhoid cream that provides relief from hemorrhoid pain, itching and burning without the use of vasoconstrictors. Vasoconstrictors can negatively affect other health issues like high blood pressure.

  • APhA Foundation project uses collaborative care to target diabetes among vulnerable populations

    WASHINGTON — A project by the philanthropic wing of the American Pharmacists Association to include pharmacists on diabetes care teams in highly affected and underserved communities has produced significant decreases in blood-sugar levels among patients, according to results released Thursday.

  • Reckitt Benckiser poised to drive growth within VMS space

    SLOUGH, England — Reckitt Benckiser has realized a greater value out of its 1-year-old acquisition of Schiff, which moved the consumer product goods conglomerate into the dietary supplement arena, and expects to push that VMS business to greater heights in the coming year, Rakesh Kapoor, Reckitt Benckiser CEO and executive director told analysts during a conference call Tuesday. 

  • Depomed sells royalty, milestone interests in Type 2 diabetes drugs for $240.5 million

    NEWARK, Calif. — Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.

    The drug maker announced that it had sold its interest in the Type 2 diabetes therapeutic area to PDL for $240.5 million, which it plans to use to acquire rights to products it said would drive long-term growth and build on its expertise in pain and neurology.

  • IRI, SPINS partner on new natural, organic customer segmentation

    CHICAGO — To assist CPG manufacturers and retailers in generating new levels of growth through a better understanding of these shopper needs, Information Resources joined forces with SPINS to create SPINS NaturaLink, a new segmentation of the total U.S. population, which focuses on how shoppers think about, purchase and use natural/organic/ecofriendly products, the two firms announced Tuesday.

  • WebMD launches web-based flu-tracking map

    NEW YORK — WebMD Health on Monday announced the availability of the WebMD Cold and Flu Symptoms Across the Nation map and companion health center to help consumers stay ahead of cold and flu symptoms this season.  

X
This ad will auto-close in 10 seconds